Your browser doesn't support javascript.
loading
"ET Plus": Instability of the Diagnosis During Prospective Longitudinal Follow-up of Essential Tremor Cases.
Iglesias-Hernandez, Daniella; Delgado, Nikki; McGurn, Margaret; Huey, Edward D; Cosentino, Stephanie; Louis, Elan D.
Afiliação
  • Iglesias-Hernandez D; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Delgado N; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • McGurn M; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Huey ED; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Cosentino S; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Louis ED; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, United States.
Front Neurol ; 12: 782694, 2021.
Article em En | MEDLINE | ID: mdl-34975736
ABSTRACT

Background:

A recent consensus statement introduced the term "ET plus". Although investigators have quantified the prevalence of ET plus in cross-sectional studies, patients with ET plus have not been tracked longitudinally; hence, there is no understanding of its stability over time.

Methods:

We present prospective, longitudinal phenotypic data on an ET cohort that was followed regularly at 18-month intervals (T1, T2, T3, T4) for up to 64 months. We assigned an ET or ET plus diagnosis to each case at each time interval.

Results:

There were 201 participants at baseline. The proportion with ET plus increased from 58.7% at baseline to 72.1% at T4 (p = 0.046). Of 172 (85.6%) who received a diagnosis of ET plus at one or more time intervals, the diagnosis was unstable (e.g., with reversion) in 62 (36.0%). We also assessed the stability of the clinical features of ET plus. Rest tremor was the most unstable clinical feature of ET plus; it was present in 59 participants, among whom it reverted from present to absent in 23 (39.0%). By contrast, for "memory impairment" (i.e., either mild cognitive impairment or dementia), the proportion who reverted from present to absent was only 21.3%.

Conclusion:

These data support our two a priori hypotheses (1) the prevalence of ET plus would increase progressively, as it likely represents a more advanced stage of ET, and (2) the ET plus diagnosis would not be stable over time, as cases would fluctuate with respect to their phenotypic features and their assigned diagnoses.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article